DealForma Research

Recent Articles

Autoimmune R&D Partnerships, M&A, Ventures, and IPOs in 2024

April 20, 2025

Global Healthcare and Life Sciences – Q1 2025 Review

April 14, 2025

Neurologic R&D Partnerships, M&A, Ventures, and IPOs in 2024

April 14, 2025

Cancer R&D Partnerships, M&A, Ventures, and IPOs in 2024

April 1, 2025

MedTech R&D Partnerships, M&A and Ventures in 2024

March 25, 2025

Biopharma Therapeutics and Platforms IPO Activity in 2024

March 19, 2025

Large Market Cap Biopharma M&A 2023 & 2024

March 11, 2025

Biopharma Therapeutics and Platforms Venture Funding in 2024

March 5, 2025

Biopharma Therapeutics and Platforms M&A in 2024

March 5, 2025

Biopharma Therapeutics and Platforms R&D Partnerships 2024

February 21, 2025

Global Healthcare and Life Sciences IPO Activity – 2024 Review

February 21, 2025

Global Healthcare and Life Sciences Venture Funding – 2024

February 8, 2025

Global Healthcare and Life Sciences M&A – 2024 Review

February 8, 2025

All of this by stage, disease indication, modality, target…

+ 0 k

Licensing Deals

+ 0 k

M&A

+ 0 k

Other Deals

+ 0 k

Funding Rounds

+ 0 k

Company Profiles

+ 0 k

Drug Sales Figures